This article is part of the HBOT Radar series, where we summarize the latest published hyperbaric oxygen therapy research.
Fresh Science, Clearly Explained — Brought to you by Brain Spa Hyperbaric
Disclaimer: This article is intended for educational and informational purposes only. It summarizes published medical research conducted in clinical settings and does not evaluate Brain Spa Hyperbaric products. The hyperbaric chambers offered on this website are non-medical wellness devices and are not intended to diagnose, treat, cure, or prevent any disease. Do not make medical decisions based on this article — consult a qualified healthcare professional.
📌 After a Spinal Cord Injury, There's a Race Against Time. Could Oxygen Tip the Scales?
🔍 Why this topic matters
When someone breaks their back or neck badly enough to damage the spinal cord, the initial impact is only the beginning. What happens in the hours and days afterward — the so-called "secondary injury cascade" — often determines whether someone walks again or doesn't.
Here's why: the initial trauma ruptures blood vessels in and around the spinal cord, cutting off oxygen to surrounding tissue. Within hours, a chain reaction kicks in — swelling, inflammation, oxidative stress, and cell death that can spread well beyond the original injury site. Neurons that survived the initial impact start dying simply because they can't get enough oxygen. It's as if the injury keeps expanding from within.
This secondary damage is actually the most promising therapeutic target, because unlike the initial trauma (which has already happened by the time doctors see you), the secondary cascade unfolds over hours to weeks — a window where intervention might make a difference.
The question that's haunted spinal cord injury (SCI) research for decades: what if you could flood that oxygen-starved tissue with extra oxygen during that critical window?
An Italian team from the University of Salerno tackled this by conducting the most comprehensive review to date — 50 studies, 1,102 patients, spanning nearly five decades of research from 1978 to 2024. And they included a dramatic case from their own hospital to illustrate what the data looks like in a real patient.
🔬 What the researchers reviewed
This is a hybrid study: a systematic review conducted under PRISMA 2020 guidelines, combined with an illustrative clinical case from the authors' own practice.
They searched PubMed, OVID Medline, and Google Scholar for studies published between 1978 and 2024. Out of 789 initial records, 50 studies met their inclusion criteria — covering both traumatic SCI (think car accidents, falls, diving injuries) and non-traumatic SCI (decompression sickness, radiation damage, infections, surgical complications). Study types ranged from randomized controlled trials to case reports.
Because the studies were so different from each other in design, patient populations, and protocols, a statistical meta-analysis wasn't possible. Instead, the researchers did what's called a qualitative synthesis — carefully organizing and interpreting the evidence by theme.
📊 What the evidence shows
The case that brings the numbers to life
Before diving into the data, the researchers present a patient from their own hospital — and it's the kind of case that sticks with you.
A 67-year-old man was brought in after a car accident. He couldn't move any four limbs (tetraplegia), had lost bladder and bowel control, and couldn't speak properly. MRI showed bleeding inside his spinal cord at the C4 level. He was classified as AIS B — meaning he had some sensation but no useful movement below the injury.
HBOT was started on day two — 1.8 ATA for 60 minutes per session. By session 10, he had regained anal sphincter control, recovered neck muscle strength, and his speech was improving. After 19 sessions, he had improved from AIS B to AIS D — meaning he had regained useful movement. MRI confirmed the spinal cord swelling was resolving. He was eventually discharged to rehab, and at final follow-up could sit independently and move using an electric wheelchair.
One case doesn't prove anything — the researchers are clear about that. But it vividly illustrates the kind of trajectory the larger data suggests is possible.
Traumatic spinal cord injuries: timing and completeness matter enormously
Across 13 studies covering 236 patients with traumatic SCI, a consistent pattern emerged:
Incomplete injuries respond much better than complete ones. In one study by Tan et al., 86.2% of patients with incomplete injuries achieved at least one grade of improvement on the standard neurological scale (ASIA Impairment Scale) after HBOT, with MRI evidence of reduced lesion size. In contrast, an early study by Gamache et al. found that while 4 out of 25 patients with incomplete injuries improved substantially, not a single patient with complete paralysis recovered any function.
Earlier treatment appears to produce better results. Ishihara et al. observed that patients who responded to HBOT in the first day or two after surgery went on to achieve the greatest long-term recovery — most reaching near-normal function. Studies where HBOT was delayed weeks or months showed much less dramatic improvements.
A randomized trial by Sun et al. found greater neurological gains in the HBOT group compared to controls — one of the stronger pieces of evidence in this field, though the study was small.
Non-traumatic spinal cord injuries: a mixed but intriguing picture
The non-traumatic data is larger (870 patients across 37 studies) but messier, because "non-traumatic SCI" covers wildly different conditions — from diving-related decompression sickness to radiation damage to spinal infections.
Decompression sickness — by far the largest subgroup (73% of patients) — showed the strongest results. This makes biological sense: decompression injury is essentially a sudden, severe oxygen deprivation event, and HBOT directly addresses this by dissolving nitrogen bubbles and restoring oxygen delivery.
Radiation-related spinal cord injury showed encouraging results in case reports, though the evidence base is small.
Across all non-traumatic causes combined: full neurological recovery was observed in 29.5% of patients, partial improvement in 44.8%, persistent deficits in 21.6%, and no benefit or worsening in 4.1%. Those are genuinely encouraging numbers — though the lack of proper control groups in most studies means we can't be certain how many patients would have improved without HBOT.
The honest complication: everything else these patients received
Here's the elephant in the room that the reviewers themselves flag prominently: almost every patient in these studies also received other treatments — corticosteroids, surgical decompression, antibiotics, intensive rehabilitation. Separating HBOT's contribution from the effect of standard care is essentially impossible in most of the included studies.
⚖️ Where the evidence is strong — and where it isn't
Where the signal is strongest:
- Incomplete traumatic SCI treated with HBOT early (within hours to days) — multiple studies, including one RCT, suggest meaningful neurological improvement
- Decompression sickness — strong rationale and the most consistent positive results, though HBOT is already standard treatment for this condition
- The secondary injury cascade is a well-established therapeutic target, and the biological mechanism for why HBOT might help is rock-solid
Where the evidence falls short:
- Complete spinal cord injuries (AIS A) — the data consistently suggests these patients don't benefit from HBOT, likely because the damage is too extensive for oxygen alone to reverse
- Standardized protocols don't exist — pressures ranged from 1.8 to 6.0 ATA (!), sessions from 2 to 127, and timing from hours to years after injury. This makes it nearly impossible to say "this specific approach works"
- Only a handful of true randomized controlled trials exist in this entire 50-study review — the vast majority are case reports, case series, and retrospective analyses
What we still don't know:
- The optimal timing, pressure, and number of sessions for SCI
- Whether HBOT's benefits hold up in large, well-controlled trials
- How much of the observed improvement is due to HBOT versus concurrent treatments like surgery, steroids, and rehabilitation
📌 Takeaway for the community
- The largest review to date (50 studies, 1,102 patients, spanning 1978-2024) found that HBOT was most consistently associated with neurological improvement in incomplete spinal cord injuries treated early after injury
- In traumatic SCI, one study observed that 86.2% of patients with incomplete injuries improved by at least one neurological grade with HBOT — but complete injuries showed minimal to no response
- Earlier HBOT initiation (hours to days after injury) was associated with better outcomes than delayed treatment across multiple studies
- The absence of standardized protocols and the scarcity of randomized controlled trials are the biggest barriers to definitive conclusions — nearly every study used different pressures, session counts, and timing
- All studies used clinical-grade HBOT at 1.8-3.0 ATA with 100% medical oxygen in hospital settings — not comparable to consumer wellness chambers
Source: https://www.mdpi.com/2076-3425/16/2/165
Iaconetta G, Ranalli C, Rosso Antonino J, Siglioccolo A, Narciso N, Scrofani R, Amoroso E, Cascella M, De Simone M. Hyperbaric Oxygen Therapy in Traumatic and Non-Traumatic Spinal Cord Injuries: Insights from Nearly Five Decades of Evidence with Single-Center Experience. Brain Sci. 2026;16(2):165. doi: 10.3390/brainsci16020165.
Educational disclaimer
This content summarizes findings from published medical research for educational purposes only.
The hyperbaric chambers sold on this website are non-medical wellness devices and are not intended to diagnose, treat, cure, or prevent any disease.
The studies discussed here were conducted in clinical medical settings using medical-grade interventions. The inclusion of research summaries does not imply that similar outcomes can be achieved using non-medical wellness devices.
